U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518342) titled 'The Effect of Nanofat Injection on Androgenetic Alopecia' on March 29.
Brief Summary: Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Androgenetic Alopecia
Androgenetic Alopecia (AGA)
Intervention:
DRUG: Minoxidil 5 %
Topical application of minoxidil 5%
PR...